{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoKWX1-sJDA","lastupdate":"2024-01-11T00:00:00.000Z","update_date":"2024-01-11T00:00:00.000Z","lastModified":"Feb 19, 2025","active":1,"confidence_score":90,"confidence_score_reason":"video or image, markets, not claimed","urlname":"envizion-medical","minimal_profile":null,"status":"Acquired","fullstatus":"Acquired by Alpha Capital Anstalt on Jul, 2024","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$ZWtPcGi2evlp0fV4AKfu1NaAoUILatLsRZSro38jMGzs5N7cqNrRNh","name":"Envizion Medical","oneliner":"Body Navigation for Enteral Feeding Tube Placement","registrar":"515724706","website":"https://www.envizionmed.com","careerspage":"","founded_month":9,"founded_year":2017,"formernames":["Nutriseal"],"sociallinks":{"twitter":"","youtube":"","facebook":"https://www.facebook.com/ENvizionMed","linkedin":"https://www.linkedin.com/company/11683782","instagram":""},"social":["https://www.linkedin.com/company/11683782","https://www.facebook.com/ENvizionMed"],"flattenedsociallinks":"https://www.linkedin.com/company/11683782|https://www.facebook.com/ENvizionMed","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":18,"patent":1,"raised":24200000,"stage":"Acquired","public_stage":"Acquired","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Envision Medical"],"about":"ENvizion Medical develops solutions for enteral feeding. The company's lead product may dramatically reduce the occurrence of misguided tube insertion during nasoenteral feeding and ensures the tube is placed safely and positioned for effective feeding.\r\n\r\nThe ENvizion solution is designed for patients in intensive care units, pediatric departments, and nursing homes. ENvizion Medical's FDA-cleared product is powered by electromagnetic navigation tube placement technology and ENvue-compliant sump/feeding tubes.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972722288240","country":null,"address":{"israeli":[{"id":"408e2487-2614-404a-b823-59fd2ab1d648","city":"Tel Aviv-Yafo","type":null,"address":"HaBarzel St 26, Tel Aviv-Yafo, Israel","placeid":"ChIJMe2eLetJHRUR7x5zixdZe5U","notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"b65ceec6-d1cf-468d-af50-e51710e61a6b","city":null,"address":"Illinois, USA","country":"United States","placeid":"ChIJGSZubzgtC4gRVlkRZFCCFX8"}]},"headquarter_address":null,"district":"Center District","news":[{"id":"cTpUEmgGPZaLUGvgINuVk2FS567ZPKfrKwWRL2Jsw8pxPc3br3A8Hx","date":"Feb 14, 2025","link":"https://markets.businessinsider.com/news/stocks/nanovibronix-completes-acquisition-of-envue-medical-1034363174","source":"markets.businessinsider.com","visible":1,"analysis":{"tags":"acquisition","round":null,"company":"NanoVibronix","layoffs":null,"summary":"NanoVibronix has completed the acquisition of ENvue Medical Holdings, a strategic move aimed at enhancing its market position in the medical device sector, particularly in enteral feeding technology. This acquisition, structured as a stock-for-stock transaction, is expected to broaden the companys commercial platform and improve operational efficiencies. Additionally, NanoVibronix secured a $500,000 private placement investment from an institutional investor, with the debenture convertible into common stock. The acquisition and investment are anticipated to drive growth and expand market reach. The transaction was approved by both companies boards and stockholders, and the acquisition was finalized on February 14, 2025.","partners":null,"customers":null,"eventType":null,"investors":"institutional investor","confidence":9,"key_topics":["acquisition","investment","medical devices","market expansion","stock conversion"],"date_of_event":"February 14, 2025","product_stage":"released","investment_date":"February 14, 2025","acquired_company":"ENvue Medical Holdings","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$500,000","structured_issues":["Acquisition","Investment"],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"structuredIssuesShow":"#Acquisition  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"i9Yj2fSbLk0pMmLfMy8YPxMN4e74ibh5802uiNLKB2E18fxgpGhxom","news_summary":"NanoVibronix completes acquisition of ENvue Medical","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"PsLsIGyHd1sywRlCQBykl0iIUiHaKa0KmdpfbNURc2fnf6zVxXnOM2","date":"Jul 8, 2024","link":"https://www.envizionmed.com/press-releases/envizion-medical-is-under-a-new-owner-targeting-u-s-healthcare-market-expansion/","source":"www.envizionmed.com","visible":1,"analysis":{"tags":"acquisition","company":"ENvizion Medical Inc.","layoffs":null,"summary":"Alpha Capital Anstalt has acquired all operating assets and IP of ENvizion Medical Ltd., including ENvizion Medical Inc. Following the acquisition, ENvizion Medical Inc. will operate as a privately held entity. The company specializes in the enteral feeding tube navigation market and has developed the FDA 510(k)-cleared ENvue system, which uses electromagnetic technology for precise tube placement. The ENvue system reduces procedure times and healthcare costs, and is widely adopted in hospitals across the United States. This acquisition is expected to enhance the companys ability to deliver benefits to clinicians, patients, and customers.","partners":null,"customers":null,"investors":"Alpha Capital Anstalt","confidence":10,"key_topics":["acquisition","technology","healthcare","innovation","FDA"],"date_of_event":"Not specified","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquired-by"],"acquisition_amount":null,"structuredIssuesShow":"#Acquired-by","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"fbZXx6qvltbeFNxvPTbvUuHnEAlQs0pkq8pd2r5n8hU9CeHQS7PTRC","news_summary":"ENvizion Medical is under a new owner, Targeting U.S. Healthcare Market Expansion - Envizion Medical","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"cUNw0jrwHlBLKuKckceWVmZMC5IULMBghIqxUGPOfkpzjrgSz8lrr7","date":"May 15, 2024","link":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_2590327_0_Txtetaxjxdshwhus8sp&did=1001478865","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Acquisition, Financial Struggles","company":"Envizion Medical","layoffs":"N/A","summary":"Envizion Medical, a company that developed medical equipment for enteral feeding, has been acquired by Alpha Capital for $1.5 million. The company, which was founded in 2017, had previously raised around $24 million from private investors and the Technion Innovation Fund. Despite receiving marketing approval in the US in 2019 and going public in 2021, the company struggled to make progress with the limited capital it had raised. The companys shares have been in free fall since June 2021, with the companys value now 95% lower than when it went public.","partners":"N/A","customers":"N/A","investors":"Alpha Capital","confidence":8,"key_topics":["Acquisition","Financial Struggles","Medical Equipment","Market Entry","Investment"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-negative","investment_amount":"$24 million","structured_issues":"Acquisition","acquisition_amount":"$1.5 million","structuredIssuesShow":"#Acquisition","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"TLhXTLaeDCl9SJ4XL6ILh4EoP2FPqJ943SwUUZHg8fvW6wDRZ6bkFB","news_summary":"מסיימת את דרכה בבורסה: אנויז'ן מדיקל תימכר ב-1.5 מיליון ד' בלבד","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"GsRkdVlAx57kC3qU4ASfkGIyE5Yesg1ksNmXGp2HJAYUmhcJOspgNd","date":"Sep 4, 2023","link":"https://www.sponser.co.il/Article.aspx?_atscid=7_134353_204082920_2465486_0_Txtetaxjxdshwhus8sp&ArticleId=112980","source":"www.sponser.co.il","visible":1,"analysis":{"tags":"orders, revenue","company":"אנויז’ן","layoffs":null,"summary":"אנויז’ן דיווחה על קבלת הזמנות רכש בהיקף של 300 אלף דולר מרשת Seentaraa Healthcare. החברה צופה להכיר בהכנסות עבור ההזמנות לקראת סוף החודש הנוכחי. בנוסף, היא צפויה לרכוש זונדות בהיקף של 400-300 אלף דולר מידי שנה. אנויז’ן נמצאת בשלב ראשוני של מסחור מוצריה שהם מכשור רפורי בתחום ההזנה התוך גופית. לחברה יש גרעון בהון של 2 מיליון דולר והתחייבויות של 2.3 מיליון דולר.","partners":null,"customers":"Seentaraa Healthcare","investors":null,"confidence":8,"key_topics":["הזמנות רכש","הכנסות","זונדות","מימון","הוצאות"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"wueIEYYiu9rRfWeeXQFyRW8YKCNKXyW8hF5kCZ35tI3CS2s0D7HBZ8","news_summary":"אנויז’ן שנותרו לה מזומנים רק למספר שבועות מדווחת על הסכם הכנסות של 300 אלף דולר","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"S9sY3HfsB9zKVxXBsutdT7yxvVIVgjUiB0LEsDCtpE1nIvmFPG9h6O","date":"Jul 16, 2023","link":"https://www.funder.co.il/article/151090?_atscid=7_134353_204082920_2445523_0_Txtetaxjxdshwhus8sp","source":"www.funder.co.il","visible":1,"analysis":{"tags":"Sales, Expansion","company":"אנויזן מדיקל","layoffs":"N/A","summary":"Envision Medical, a company that sells advanced electromagnetic navigation systems that assist medical teams in safely and efficiently inserting feeding tubes, has reported the sale of its ENvue system to the University of Texas Southwestern Medical Center. The hospital, which is ranked as the best in the Dallas-Fort Worth-Arlington metropolitan area, will purchase the system and consumable products (probes) according to purchase orders provided to the company. This follows a trial period the hospital conducted with Envisions ENvue system.","partners":"N/A","customers":"University of Texas Southwestern Medical Center","investors":"N/A","confidence":9,"key_topics":"Medical Device, Sales, Hospital","date_of_event":"May 2022","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers","acquisition_amount":"N/A","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"hWIZpqkbaLawvVoEuTANrQbnm8FlmAh0PRb9VMxuAika7qXMHq2H7V","news_summary":"אנויז׳ן מדיקל מדווחת על עסקת מכירה לבית החולים הגדול בטקסס","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"cMSJUPI9xK2Mysg4fCmBpKDZRJZmgFJ6NXZEWWtHZ8BtFbVa85lrG6","date":"Apr 2, 2023","link":"https://www.sponser.co.il/Article.aspx?_atscid7_134353_204082920_2393786_0_Txtetaxjxdshwhus8sp&ArticleId111546","source":"www.sponser.co.il","visible":1,"analysis":{"summary":"The text provided is not in English and appears to be a collection of headlines or article snippets rather than a full article. Therefore, its not possible to provide a detailed summary, identify the company, classify the impact on the company, tag key issues, identify structured issues, key topics, investors, valuation amount, layoffs, investment amount, acquisition amount, customers, partners, or date of event.","confidence":0,"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"gdhN5Spa3hJHwyvyl7GwO0y82Br4exspDIPte3ArXRApAo8ZsR0VYc","news_summary":"אנויז’ן מדיקל מדווחת על מכירה של מערכות ENvue® לרשת בתי החולים Sentara בארה”ב","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"hNRH6TPMdYeBpS15HHZo3g4FTCFV3eccBusaHsrKd4WglLrRNaT2df","date":"Feb 5, 2023","link":"https://www.sponser.co.il/Article.aspx?_atscid7_134353_204082920_2362919_0_Txtetaxjxdshwhus8sp&ArticleId110925","source":"www.sponser.co.il","visible":1,"analysis":{"tags":"Stock Sale","company":"שיכון ובינוי","layoffs":"Not mentioned","summary":"שיכון ובינוי is selling shares of its real estate company to an institutional investor for a total of 400 million shekels. The companys CEO, תמיר כהן, stated that this move is another step towards strengthening the capital and improving the balance.","partners":"Not mentioned","customers":"Not mentioned","investors":"Institutional Investor","confidence":8,"key_topics":["Stock Sale","Institutional Investment","Real Estate"],"date_of_event":"Not mentioned","valuation_amount":"5 billion shekels","impact_on_company":"growth-positive","investment_amount":"400 million shekels","structured_issues":"Investment","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"kGg2IPvEkISGfDMmBsOxjVoaE63KG36Wg0viNVJaEsqbCyFxjBtNHL","news_summary":"הזרמה חריגה בחברה ציבורית: אנויז’ן מדיקל התקשרה בהסכם השקעה מסוג SAFE","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7d16cee7-34d2-451c-8a4a-fe4406331844","date":"Jul 20, 2022","link":"https://www.sponser.co.il/Article.aspx?_atscid=7_134353_204082920_2238148_0_Txtetaxjxdshwhus8sp&ArticleId=109054","source":"www.sponser.co.il","visible":1,"analysis":{"tags":"medical technology","company":"אנויז’ן מדיקל","layoffs":null,"summary":"אנויז’ן מדיקל, המשווקת ומוכרת מערכות ניווט אלקטרומגנטיות מתקדמות, דיווחה על רכישת מערכת ה-ENvue ומוצרים מתכלים מבית החולים BaylorScott & White Centennial. בחודש מאי 2022, ה-FDA פירסמה הודעה על ביצוע Recall למוצר המתחרה Cortrak 2 Enteral Access System של חברת Medical Avanos. ה-FDA דיווחה על מקרים של פציעות ומוות כתוצאה מהחדרה שגויה של צינורות הזנה. אנויז’ן קיבלה בקשות להזמנת מערכות מ-5 בתי חולים לאחר ה-Recall.","partners":null,"customers":"BaylorScott & White Centennial","investors":null,"confidence":8,"key_topics":["FDA","Recall","ENvue","BaylorScott & White Centennial","Cortrak 2 Enteral Access System"],"date_of_event":"May 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"HOpwlHgCoiqHPapwRu7M5jCITif7sUVoaSdWiKf5WuVJoz6eCT59Ae","news_summary":"אנויז'ן מזנקת 25% - מאז החלטת ה-FDA ל-Recall למוצר המתחרה אנויזן מתרחבת בצורה מהירה","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4c1358bf-9b8f-4742-acee-e6d8c34f8298","date":"Oct 18, 2021","link":"https://en.globes.co.il/en/article-envizion-medical-announces-baby-feeding-tube-with-navigation-1001387665","source":"en.globes.co.il","visible":1,"analysis":{"tags":"medical technology","company":"Envizion Medical","layoffs":null,"summary":"Envizion Medical has developed a special feeding tube for infants and premature babies and is preparing for a clinical trial to obtain FDA approval. The companys stock price has increased by over 8% in response to the announcement. Envizion Medical produces electromagnetic navigation systems for medical teams and estimates that 50% of feeding tubes are inserted incorrectly. The companys ENvue system, currently used in seventeen US hospitals, aims to improve the accuracy of tube insertion. The development of the feeding tube is seen as a breakthrough for families and neonatal wards worldwide.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["feeding tube","infants","premature babies","clinical trial","stock price"],"date_of_event":"October 18, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"e25A6uBczfvZN7Zdc7kA64jJ3ZbCZjp6YT5HyJz9pknTnBJwWo4Zxx","news_summary":"Envizion unveils baby feeding tube with navigation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"dea2c364-9ec3-44b1-a8bf-4053c8c617cb","date":"Jul 11, 2021","link":"https://www.sponser.co.il/Article.aspx?_atscid=7_134353_204082920_1920168_0_Txtetaxjxdshwhus8sp&ArticleId=105547","source":"www.sponser.co.il","visible":1,"analysis":{"tags":"medical technology","company":"אנויזן מדיקל","layoffs":null,"summary":"Inova, an American hospital network, will acquire 6 ENvue systems and thousands of feeding tubes from medical technology company ENvizion Medical. The ENvue system assists medical teams in safely and efficiently inserting feeding tubes into patients bodies. This acquisition expands ENvizions presence in the US market, where it already operates in 16 hospitals. The ENvue system, which received FDA approval in 2019, uses electromagnetic navigation technology to guide the placement of feeding tubes. The system provides advantages over blind insertion methods, which can lead to complications and infections. Inova is a healthcare provider in Virginia that serves over 2 million patients annually.","partners":null,"customers":"Inova","investors":null,"confidence":8,"key_topics":["medical technology","ENvue system","Inova hospitals","feeding tubes","medical navigation"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"aLcTp4IMjRm798lQotXJZRnSxSCkL2EhD6XhPXhbk0vhOlLyBj4V5V","news_summary":"חברת המכשור הרפואי אנויז'ן מרחיבה את פעילותה בארצות הברית","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"08ca56ab-a87c-4dc7-9a74-05e94ab78648","date":"May 27, 2021","link":"https://www.med-technews.com/news/latest-medtech-news/enteral-feeding-tube-recognised-with-north-american-innovati/","source":"www.med-technews.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"haM13qQNvfb3o7jsmatGNMc9hUqt2YPFvw6yjCfkLt4eqo9kqiy5WI","news_summary":"Enteral feeding tube recognised with North American innovation award","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"686ee756-0036-430e-a9b5-f5fd259cd1f9","date":"Feb 9, 2021","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3892710,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"IPO","company":"ENvizion Medical","layoffs":null,"summary":"ENvizion Medical, an Israeli startup that develops solutions for enteral feeding, has filed a prospectus for an initial public offering (IPO) on the Tel Aviv Stock Exchange. The company aims to raise approximately $13.9 million at a valuation of approximately $61.5 million. Leumi Partners, the investment arm of Bank Leumi, is underwriting the offering. ENvizion Medical has raised $20 million to date and its lead product utilizes electromagnetic navigation tube placement technology for safe and effective feeding. The companys estimated revenue for 2021 is around $4 million.","partners":null,"customers":null,"investors":"Leumi Partners","confidence":9,"key_topics":["ENvizion Medical","enteral feeding","IPO","fundraising","valuation"],"date_of_event":"2021-09-02","valuation_amount":"$61.5 million","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Public Trading"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Public Trading","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"FFrfOIZO0yrNwfx56b78nekTprtZTBQHFjkLPVtpAsNWUQcrqU3lkX","news_summary":"ENvizion Medical targeting TASE IPO at over $60 million valuation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ca1f646e-0488-472c-a36f-5cb891e9847e","date":"Oct 25, 2020","link":"https://www.jpost.com/health-science/meet-the-waze-of-feeding-tubes-646920","source":"www.jpost.com","visible":1,"analysis":{"tags":["medical technology","patient safety"],"company":"ENvizion Medical","layoffs":null,"summary":"ENvizion Medical, a leading innovator in the field of enteral feeding, is making significant headway in improving patient safety. The company has developed a personalized navigation system that uses multiple sensors and anatomical landmarks to safely guide feeding tubes into the small intestine. This innovation addresses the fundamental problems with traditional methods of enteral feeding and has the potential to save lives. With medical errors being a leading cause of death in the US, the demand for safe feeding protocols has increased, especially during the COVID-19 pandemic. ENvizions solution represents a significant change in the approach to enteral feeding procedures and is expected to gain support from industry leaders.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Enteral feeding","Patient safety","Medical innovation","Risk assessment","Medical errors"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"5IgbhbKURHwFUV611KAGYAQG4fdpAdIY6E9CmaifcxkW7rCql5GP5s","news_summary":"https://www.jpost.com/health-science/meet-the-waze-of-feeding-tubes-646920","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"f6b4d8d8-0821-4b0d-8305-8c7df419bd1a","date":"Sep 3, 2020","link":"https://en.globes.co.il/en/article-israeli-enteral-feeding-co-envizion-raises-18m-1001341562","source":"en.globes.co.il","visible":1,"analysis":{"tags":"medical technology","company":"ENvizion Medical","layoffs":null,"summary":"ENvizion Medical, an Israeli enteral feeding placement navigation technology company, has raised $18 million in funding and secured an agreement with a network of 100 US hospitals to provide feeding tube placement navigation devices. The companys navigation device, ENVue, can reduce the placement procedure time and provide guidance to medical-support staff. The funding was raised from private medtech backers, family offices, and the Technion Venture Capital fund. The agreement with the hospital network will allow ENvizion to distribute its devices nationwide. The need for feeding tubes has increased during the Covid-19 pandemic.","partners":null,"customers":null,"investors":"private medtech backers, family offices, Technion Venture Capital fund","confidence":9,"key_topics":["ENvizion Medical","feeding tube placement navigation devices","FDA 510(k) clearance","private hospital networks","Covid-19 pandemic"],"date_of_event":"September 3, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$18 million","structured_issues":["Customers","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"AI2EsCu7ZS0D1gWbwetrBoqbyrbXLmCGz9BND6ljlRt6gpokpNLSi5","news_summary":"Israeli enteral feeding co ENvizion raises $18m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":14,"techcommunityinvolvement":null,"mediagallery":[],"tags":["babies","feeding","medical-devices","critical-care","patients","medical-equipment","hospitals"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuDspIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":["ENvue"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":2828978,"marketcapitaldate":"2023-11-01T14:01:17.000Z","funding":{"investors":1,"lastfunding":"$6.2M","totalrounds":2,"fundingstage":"Acquired","totalfunding":"$24.2M","publicinvestors":1,"lastpublicfunding":6200000,"totalpublicrounds":2,"totalpublicfunding":24200000},"team":[{"name":"Doron Besser","email":"doronb@envizionmed.com","phone":"0542020206","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoOWe3r8LDA","bounced":false,"claimed":0,"founder":1,"urlname":"doron-besser","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgxYiCuwkM","position":"Co-founder, CEO & President","last_name":"Besser","claimtoken":"bJLokjw0Ll6Ci6GQQp2TeVcfPHbf34KoF4jxYIvSDaiXZ54RmHGYtt","first_name":"Doron","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/doronbesser/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-01-11 14:28:21.000000","initials":"DB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dr. Anat Hofshi","email":"anath@envizionmed.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoKWNqM4IDA","bounced":false,"claimed":0,"founder":0,"urlname":"dr-anat-hofshi","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgxcOh9QoM","position":"Director of Clinical Affairs","last_name":"Hofshi","claimtoken":"K6EevbTxW2dxLfoyrmqoory5rCwKyWJHQIQoyagG7mnjHH5Sbc2PWy","first_name":"Dr. Anat","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/anat-hofshi-phd-95b08051/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-01-11 14:28:19.000000","initials":"DH","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-10-07T00:00:00.000Z","crunchbaseid":"envizion-medical","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Yotam Maman","creator_email":"yotamm1988@gmail.com","createdate":"2018-07-24T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Yanina Wainscheinker","affiliatedOrganizations":null,"timeline":[{"id":"WCCjgCNWeRIrtVkcG3krZIInQ4xYVIs5BMOtC5C8pLd6VQAga9lctF","date":"Jul 2024","amount":"Undisclosed","source":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_2590327_0_Txtetaxjxdshwhus8sp&did=1001478865","ticker":null,"eventtype":"DelistingEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","duetoacquisition":"","isdelisting":1,"acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null},{"id":"BlrsIdKOLdydk6Su5pnrr4O0O81j95Z0p3p8tkU2ERA9j928asWoAD","date":"Jul 2024","amount":"Undisclosed","source":"https://www.envizionmed.com/press-releases/envizion-medical-is-under-a-new-owner-targeting-u-s-healthcare-market-expansion/","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"acquiredcompany_mna":"Alpha Capital Anstalt","acquiredcompany_mna_id":"76RFnEQG56BFeMOS2hcAFs2HJDFyzlSY9wBuTwP2Wjn8T8EeWZSd7n","acquiredcompany_mna_type":"Investor","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/investor_page/alpha-capital-anstalt-1","acquiredcompany_mna_logokey":null,"acquiredcompany_mna_urlname":"/investor_page/alpha-capital-anstalt-1","acquiredcompany_mna_homepage":"https://my.pitchbook.com/profile/128382-40/investor/profile","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"/assets/empty-state.svg","exit_label":"","po_label":"Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD35rL_CAw","date":"Jun 2021","amount":"Undisclosed","source":"https://www.globes.co.il/news/article.aspx?did=1001373165, https://maya.tase.co.il/reports/details/1374511 ","ticker":"ENVM","eventtype":"POEvent","valuation":"$45M","investment":[],"capitalraised":"$6.2M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":6200000,"valuationnumber":45000000},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODZo8qGCww","date":"Sep 2020","amount":"$18M","source":"https://en.globes.co.il/en/article-israeli-enteral-feeding-co-envizion-raises-18m-1001341562","eventtype":"FundingRoundEvent","investment":[{"name":"Technion Research & Development Foundation","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/technion-research-development-foundation-1","logokey":"$WT57F82oZhvXUSEZQMsR8SciiZH0nqkygmIGb4cR4s4KhZgsnECXaw.jpeg","tagline":"","urlname":"/investor_page/technion-research-development-foundation-1","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7qW2CQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"bf174781-c49d-4ad7-a0e2-23b1d77e3c45","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$WT57F82oZhvXUSEZQMsR8SciiZH0nqkygmIGb4cR4s4KhZgsnECXaw.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":18000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"9/2017","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Envizion Medical","logourl":"https://storage.googleapis.com/clean-finder-353810/$ZWtPcGi2evlp0fV4AKfu1NaAoUILatLsRZSro38jMGzs5N7cqNrRNh","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$ZWtPcGi2evlp0fV4AKfu1NaAoUILatLsRZSro38jMGzs5N7cqNrRNh","seoabout":"ENvizion Medical develops solutions for enteral feeding. The company's lead product may dramatically reduce the occurrence of misguided tube insertion duri...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":2,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Life Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuDspIKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Life Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuDspIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Life Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuDspIKDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Life Support","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Life Support"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Sensing","key":"0-0","path":"TechnologyClassificationModel>Sensing"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Life Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuDspIKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Life Support"],"coreTechnology":["Sensing"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"WCCjgCNWeRIrtVkcG3krZIInQ4xYVIs5BMOtC5C8pLd6VQAga9lctF","date":"Jul 2024","amount":"Undisclosed","source":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_2590327_0_Txtetaxjxdshwhus8sp&did=1001478865","ticker":null,"eventtype":"DelistingEvent","valuation":"Undisclosed","investment":[],"capitalraised":"Undisclosed","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"","po_label":"Public Offering","duetoacquisition":"","isdelisting":1,"acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":null,"valuationnumber":null},{"id":"BlrsIdKOLdydk6Su5pnrr4O0O81j95Z0p3p8tkU2ERA9j928asWoAD","date":"Jul 2024","amount":"Undisclosed","source":"https://www.envizionmed.com/press-releases/envizion-medical-is-under-a-new-owner-targeting-u-s-healthcare-market-expansion/","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"acquiredcompany_mna":"Alpha Capital Anstalt","acquiredcompany_mna_id":"76RFnEQG56BFeMOS2hcAFs2HJDFyzlSY9wBuTwP2Wjn8T8EeWZSd7n","acquiredcompany_mna_type":"Investor","acquiredcompany_mna_hidden":true,"acquiredcompany_mna_fullurl":"/investor_page/alpha-capital-anstalt-1","acquiredcompany_mna_logokey":null,"acquiredcompany_mna_urlname":"/investor_page/alpha-capital-anstalt-1","acquiredcompany_mna_homepage":"https://my.pitchbook.com/profile/128382-40/investor/profile","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"/assets/empty-state.svg","exit_label":"","po_label":"Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD35rL_CAw","date":"Jun 2021","amount":"Undisclosed","source":"https://www.globes.co.il/news/article.aspx?did=1001373165, https://maya.tase.co.il/reports/details/1374511 ","ticker":"ENVM","eventtype":"POEvent","valuation":"$45M","investment":[],"capitalraised":"$6.2M","stockexchange":"TASE","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCot526Cgw","stockexchange_logokey":"$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","style":"","hiddenCompanyTooltip":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$lbzaT2u1ZZsaxZoI8dlPGaVypdtKjf7mkYzKR0EFwkK0sKlf9u3hyJ","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraisednumber":6200000,"valuationnumber":45000000}],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODZo8qGCww","date":"Sep 2020","amount":"$18M","source":"https://en.globes.co.il/en/article-israeli-enteral-feeding-co-envizion-raises-18m-1001341562","eventtype":"FundingRoundEvent","investment":[{"name":"Technion Research & Development Foundation","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/technion-research-development-foundation-1","logokey":"$WT57F82oZhvXUSEZQMsR8SciiZH0nqkygmIGb4cR4s4KhZgsnECXaw.jpeg","tagline":"","urlname":"/investor_page/technion-research-development-foundation-1","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7qW2CQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"bf174781-c49d-4ad7-a0e2-23b1d77e3c45","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$WT57F82oZhvXUSEZQMsR8SciiZH0nqkygmIGb4cR4s4KhZgsnECXaw.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":18000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}